8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2021 / Randomized, double-blind, three-arm pilot trial
In a randomized, double-blind, three-arm pilot study, 24 healthy participants were assigned to a single dose of 2.5 g resveratrol combined with 0 mg, 5 mg, or 25 mg of piperine. Serum levels were analyzed through 24 hours post-dose, and adverse events were monitored for 30 days. Pharmacokinetic values for resveratrol showed Cmax of 18.5 ± 16 ng/mL for resveratrol alone, 29 ± 29 ng/mL with 5 mg piperine, and 16 ± 13 ng/mL with 25 mg piperine, with no significant relationship between dose and pharmacokinetic values. All subjects tolerated the therapy with minimal to no toxicity.
Bailey HH, Johnson JJ, Lozar T, et al. Eur J Cancer Prev, 2021. PMID 32868637
2021 / Randomized, double-blind, placebo-controlled crossover trial
A randomized, double-blind, placebo-controlled crossover trial evaluated 12 weeks of once-daily oral semaglutide versus placebo in 15 subjects with type 2 diabetes. In 13 evaluable subjects, total daily ad libitum energy intake was significantly lower by 38.9% with oral semaglutide versus placebo (estimated treatment difference: -5096.0 kJ; 95% CI -7000.0, -3192.1; P = .0001). Satiety, hunger, and overall appetite scores significantly favored semaglutide after a fat-rich breakfast, alongside fewer food cravings and better eating control. Mean body weight decreased by 2.7 kg with oral semaglutide compared to 0.1 kg with placebo, primarily due to loss of body fat mass.
Gibbons C, Blundell J, Tetens Hoff S, et al. Diabetes Obes Metab, 2021. PMID 33184979
2021 / Prospective single-arm pilot study
Ten cirrhotic patients experiencing muscle cramps at least once per week were administered an oral taurine solution (1 g thrice daily) for 4 weeks, followed by a 4-week discontinuation. Muscle cramp scores decreased in seven patients by weeks 4 and 8. Median cramp scores dropped from 21 (IQR: 8-84) at baseline to 6.5 (IQR: 3-12, p=0.126) at week 4 and 5 (IQR: 1.5-56, p=0.066) at week 8. Improvements in muscle cramps at week 4 were reported by 60% of patients with low baseline taurine levels and 80% of patients with normal or higher baseline levels.
Jang ES, Hwang SH, Kim JW, et al. Yonsei Med J, 2021. PMID 33381931
2021 / Randomized crossover inpatient trial
Twenty inpatients were randomized to consume ad libitum either a minimally processed, plant-based, low-fat diet (10.3% fat, 75.2% carbohydrate) or an animal-based, ketogenic, low-carbohydrate diet (75.8% fat, 10.0% carbohydrate) for 2 weeks, followed immediately by the alternate diet. One participant withdrew due to hypoglycemia during the low-carbohydrate diet. The low-fat diet led to 689 ± 73 kcal d-1 less energy intake over 2 weeks (P < 0.0001) and 544 ± 68 kcal d-1 less over the final week (P < 0.0001) compared to the low-carbohydrate diet.
Hall KD, Guo J, Courville AB, et al. Nat Med, 2021. PMID 33479499
2021 / Supplementation trial
Eight male participants received 1000 mg/day of nicotinamide riboside (NR) or cellulose placebo for 1 week to evaluate metabolic and skeletal muscle responses to a 1-hour cycling bout. NR supplementation had no effect on substrate utilization at rest or during exercise, nor on skeletal muscle mitochondrial respiration. It also did not alter skeletal muscle NAD+ concentration, global acetylation, auto-PARylation of PARP1, or acetylation of p53 Lys382 and MnSOD Lys122. However, NR increased concentrations of deaminated NAD+ precursors (NAR and NAM) and methylated breakdown products (Me2PY and Me4PY).
Stocks B, Ashcroft SP, Joanisse S, et al. J Physiol, 2021. PMID 33492681
2021 / Randomized, double-blind, placebo-controlled crossover trial & in vitro study
Researchers investigated the effects of nicotinamide riboside (NR) on brown adipose tissue (BAT) in mice, in vitro human adipocytes, and human volunteers. In vitro, NR enhanced norepinephrine-stimulated mitochondrial uncoupling in primary adipocytes from human BAT. However, in a randomized, double-blind, placebo-controlled crossover study of human volunteers receiving 1000 mg/day NR for 6 weeks, NR supplementation did not alter in vivo BAT activity or cold-induced thermogenesis.
Nascimento EBM, Moonen MPB, Remie CME, et al. J Clin Endocrinol Metab, 2021. PMID 33524145
2021 / Randomized between-subjects trial
Preschoolers were randomized to either a FRUIT ONLY smoothie condition (n=36) or a FRUIT+DGV smoothie condition containing spinach, collards, and kale (n=32) to measure acceptance and ad libitum intake. In the FRUIT+DGV condition, 84.3% of children willingly tasted all five green smoothies, rating them as moderately liked (2.3 ± 0.1). During an ad libitum snack session, children in the FRUIT+DGV condition drank 225.7 ± 31.4 g of their most preferred green smoothie, delivering 18.3 ± 3.7 g of dark green vegetables and meeting 31% of their weekly USDA recommendations. Willingness to try, liking, and total intake did not differ significantly between smoothie conditions.
Rollins BY, Stein W, Keller KL, et al. Appetite, 2021. PMID 33549836
2021 / Randomized controlled trial
In a 1-year randomized controlled trial, 208 healthy older adults were assigned to carbohydrate (CARB), collagen (COLL), whey protein (WHEY), light resistance training plus whey (LITW), or heavy resistance training plus whey (HRTW). COLL and WHEY alone did not affect any measured parameter compared to CARB. Compared to WHEY, HRTW increased quadriceps cross-sectional area (+1.68 cm2; 95% CI: +0.41 to +2.95 cm2; P = 0.03), dynamic strength (+18.4 Nm; P < 10-4), and isometric strength (+23.9 Nm; P < 10-5), while LITW improved dynamic knee extensor strength (+13.7 Nm; P = 0.01) without improving muscle size.
Mertz KH, Reitelseder S, Bechshoeft R, et al. Am J Clin Nutr, 2021. PMID 33564844
2021 / 10-week randomized, placebo-controlled, double-blind trial
A 10-week, randomized, placebo-controlled, double-blind trial evaluated the effects of nicotinamide mononucleotide (NMN) supplementation on metabolic function in overweight or obese postmenopausal women with prediabetes. Insulin-stimulated glucose disposal, evaluated using a hyperinsulinemic-euglycemic clamp, and skeletal muscle insulin signaling (AKT and mTOR phosphorylation) increased after NMN supplementation but did not change after placebo. Additionally, NMN supplementation up-regulated platelet-derived growth factor receptor β and other genes involved in muscle remodeling.
Yoshino M, Yoshino J, Kayser BD, et al. Science, 2021. PMID 33888596
2021 / Double-blind, randomized, placebo-controlled trial
A double-blind, placebo-controlled trial evaluated daily supplementation with a fruit and vegetable concentrate (FVC) and high-fiber component across 57 pre-menopausal, overweight/obese female healthcare workers over five months. FVC supplementation had no effect on blood lipids, glucose, or immune parameters, but improved glucose clearance. FVC did not alter phyla-level taxonomy or alpha/beta diversity, but reduced Bacteroides abundance and increased fecal butyrate; adding a high-fiber component improved levels of health-associated bacteria.
van der Merwe M, Moore D, Hill JL, et al. Microorganisms, 2021. PMID 33920059
2021 / Videorecorded laboratory feeding experiment
In the Good Tastes Study, 106 caregiver-child dyads (children aged 6-24 months) were offered 4 versions of puréed kale: plain, 1.2% or 1.8% added sugar, or 0.2% added salt. Infants 6 to <12 months accepted more tastes (b = 2.911, P < 0.001) and were rated by caregivers as liking kale more than toddlers ≥18 months (b = 1.874, P = 0.014). Plain kale was more likely to be accepted (P < 0.001), showing no advantage of bitterness reduction by adding sugar or salt. The authors concluded there may be a sensitive period during early complementary feeding to improve success introducing novel bitter foods.
Johnson SL, Moding KJ, Grimm KJ, et al. J Nutr, 2021. PMID 34191021
2021 / Randomized, double-blind, controlled trial
A randomized, double-blind, controlled trial evaluated the effects of 32 days of NAD+-precursor supplementation (207.5 mg niacin equivalents/day from tryptophan, nicotinic acid, and nicotinamide) versus control in 14 older adults with impaired physical function. Skeletal muscle NAD+ concentrations were not significantly different between intervention and control (7.5 ± 1.9 vs 7.9 ± 1.6 AU), although methyl-nicotinamide levels were significantly higher (0.098 ± 0.063 vs 0.025 ± 0.014; P = 0.001). Neither ADP-stimulated mitochondrial respiration (82.1 ± 19.0 vs 84.0 ± 19.2; P = 0.716), maximally uncoupled mitochondrial respiration (103.4 ± 30.7 vs 108.7 ± 33.4; P = 0.495), nor net exercise efficiency (20.2 ± 2.77 vs 20.8 ± 2.88; P = 0.342) improved with supplementation.
Connell NJ, Grevendonk L, Fealy CE, et al. J Nutr, 2021. PMID 34191033
2021 / Randomized, double-blind, placebo-controlled, 4-arm clinical trial
A 6-week randomized, double-blind, placebo-controlled trial evaluated 48 recreationally trained runners assigned to placebo or 300, 600, or 1200 mg/day of nicotinamide mononucleotide (NMN) alongside 40-60 minute exercise sessions 5-6 times weekly. Oxygen uptake (VO2), percentages of VO2max, and power at both the first and second ventilatory thresholds increased to a higher degree in the medium and high dosage groups compared to control. However, there was no difference in VO2max, O2-pulse, VO2 related to work rate, or peak power after the 6-week treatment from baseline across any groups.
Liao B, Zhao Y, Wang D, et al. J Int Soc Sports Nutr, 2021. PMID 34238308
2021 / 16-week, double-blind, randomized, placebo-controlled trial
A 16-week, double-blind, randomized, placebo-controlled trial investigated whether nutritional supplements enhance adaptations to twice-weekly resistance training in 200 pre-frail and frail elderly individuals. Across four sub-investigations, leucine supplementation was ineffective for improving muscle mass and function, and whey, soy, or creatine (alone or combined) failed to enhance resistance training adaptations. Furthermore, no sex-based differences were observed in response to whey. Resistance exercise alone increased muscle mass and function in all sub-investigations, and no adverse effects were reported.
Roschel H, Hayashi AP, Fernandes AL, et al. Clin Nutr, 2021. PMID 34358827
2020 / Double-blind cross-over trial
Twelve young and twelve old men received acute nicotinamide riboside (NR) or placebo in a double-blind cross-over study. NR supplementation increased NADH (51% young; 59% old) and NADPH (32% young; 38% old) in both groups, but only in older men did it decrease urine F2-isoprostanes by 18% (P < 0.05) and tend to raise glutathione (P = 0.078). In older individuals, NR improved isometric peak torque by 8% (P = 0.048) and the fatigue index by 15% (P = 0.012), while having no effect on VO2max, concentric peak torque, or physiological performance in young men.
Dolopikou CF, Kourtzidis IA, Margaritelis NV, et al. Eur J Nutr, 2020. PMID 30725213
2020 / Pre-post intervention study
An experiential education program was conducted with 30 nurse practitioners, registered nurses, and physicians who followed a whole-food plant-based (WFPB) diet for 3 weeks. Preintervention and postintervention questionnaires assessed various health and professional outcomes. Participants decreased their intake of animal-derived foods, increased WFPB food intake, lost weight, and experienced improvements in mood and energy. Additionally, perceived barriers to following and counseling about a WFPB diet declined, self-efficacy improved, and participants were likely to continue the diet and discuss it with patients.
Lessem A, Gould SM, Evans J, et al. J Am Assoc Nurse Pract, 2020. PMID 31577667
2020 / Single-arm non-randomized trial
Ten healthy men received single oral doses of 100, 250, and 500 mg nicotinamide mononucleotide (NMN), with clinical parameters and NMN metabolite pharmacokinetics monitored for 5 hours after each intervention. The single oral doses caused no significant clinical symptoms or changes in heart rate, blood pressure, oxygen saturation, body temperature, ophthalmic examination, or sleep quality. Laboratory analyses showed increases in serum bilirubin and decreases in serum creatinine, chloride, and blood glucose within normal ranges, independent of dose. Plasma concentrations of N-methyl-2-pyridone-5-carboxamide and N-methyl-4-pyridone-5-carboxamide increased significantly in a dose-dependent manner.
Irie J, Inagaki E, Fujita M, et al. Endocr J, 2020. PMID 31685720
2020 / Randomized, placebo-controlled clinical trial
In a randomized, placebo-controlled trial, 40 middle-aged, obese, insulin-resistant men received 1000 mg nicotinamide riboside (NR) or placebo twice daily for 12 weeks. NR supplementation decreased NAMPT protein levels in skeletal muscle by 14%, but steady-state NAD+ levels and other biosynthetic enzymes were unchanged. NR did not affect skeletal muscle mitochondrial respiratory capacity, mitochondrial-associated protein abundance, mitochondrial fractional area, or network morphology.
Dollerup OL, Chubanava S, Agerholm M, et al. J Physiol, 2020. PMID 31710095
2020 / 12-month double-blind randomized controlled trial
A 12-month randomized controlled trial evaluated 20 g twice daily whey-enriched protein supplementation versus an isocaloric placebo and a no-supplement control in 218 older people with sarcopenia, with all given instructions on home-based exercise, dietary protein, and vitamin D (20 μg/d). The supplements had no significant effect on physical performance; 12-month changes in short physical performance battery scores were -0.55, -0.05, and 0.03 points across control, isocaloric, and protein groups (P = .17), with similar changes in continuous summary physical performance scores (P = .76). Hand grip strength decreased significantly in all groups, calf muscle index showed no differences between groups, and post-trial follow-up found no differences in all-cause mortality or physical functioning. Mild gastrointestinal adverse effects were reported by 56% in both supplement groups.
Björkman MP, Suominen MH, Kautiainen H, et al. J Am Med Dir Assoc, 2020. PMID 31734121
2020 / Double-blind, randomized crossover trial
In two study parts, healthy lean men received intragastric quinine (275 mg or 600 mg) or control 30 minutes before a mixed-nutrient drink (part A, n=15) or a buffet meal (part B, n=12). Alone, both doses modestly stimulated insulin (P < 0.05). Following the drink, both quinine doses reduced plasma glucose and stimulated insulin (P < 0.05); 275 mg stimulated GLP-1 (P < 0.05), while 600 mg showed a trend toward stimulating GLP-1 (P = 0.066) and glucagon (P = 0.073). Quinine did not alter gastric emptying of the nutrient drink or subsequent buffet energy intake.
Bitarafan V, Fitzgerald PCE, Little TJ, et al. Am J Physiol Regul Integr Comp Physiol, 2020. PMID 31774306
2020 / Crossover feeding trial
Thirteen healthy young men consumed a control diet for 2 weeks followed by 5 days of an isocaloric high-fat diet (HFD; 55% fat, 25% saturated). Intestinal permeability and responses to a high-fat meal challenge were evaluated before and after the HFD. Intestinal permeability was not affected by the HFD (p > 0.05), but fasting endotoxin increased two-fold (p = 0.04). Skeletal muscle glucose and fatty acid oxidation increased post-meal before the HFD (+97% and +106%) but decreased post-meal after the HFD (-24% and +16%, respectively), while insulin sensitivity remained unchanged.
Bowser SM, McMillan RP, Boutagy NE, et al. Metabolism, 2020. PMID 31785256
2020 / Within-subject controlled trial (contralateral leg design)
Twelve healthy young men performed resistance exercise followed by 20 minutes of leg immersion with one leg in cold water (8°C: CWI) and the other in thermoneutral water (30°C: CON), followed by ingestion of 20 g intrinsically labelled milk protein with 45 g carbohydrates. Incorporation of dietary protein-derived l-[1-13C]-phenylalanine was significantly lower in CWI versus CON (0.016 ± 0.006 vs. 0.021 ± 0.007 MPE; P = 0.016). Acute myofibrillar protein synthesis rates over 5 hours were lower in CWI based on l-[1-13C]-leucine (0.058 ± 0.011 vs. 0.072 ± 0.017% h-1; P = 0.024) and l-[ring-2H5]-phenylalanine (0.042 ± 0.009 vs. 0.053 ± 0.013% h-1; P = 0.025). Furthermore, daily myofibrillar protein synthesis rates over 2 weeks were significantly lower in CWI compared to CON (1.48 ± 0.17 vs. 1.67 ± 0.36% day-1; P = 0.042).
Fuchs CJ, Kouw IWK, Churchward-Venne TA, et al. J Physiol, 2020. PMID 31788800
2020 / Randomized crossover trial
Fifty healthy adults completed a randomized crossover trial comparing four weeks of daily non-fried potato side dishes against refined grains. Fasting plasma glucose did not differ between treatments (-0.05 mmol/l, 95% CI -0.14 to 0.04, P = 0.15), and no differences emerged for cardiometabolic endpoints. Potato consumption resulted in higher Healthy Eating Index-2015 scores (difference 3.5, 95% CI 0.6 to 6.4), potassium (547 mg, 95% CI 331 to 764), and dietary fiber (2.4 g, 95% CI 0.6 to 4.2).
Johnston EA, Petersen KS, Kris-Etherton PM Br J Nutr, 2020. PMID 31964428
2020 / 3-month self-selection pilot trial
A 3-month self-selection pilot study evaluated a watermelon-focused Inflammation Management Intervention (n = 15) versus basic health education controls (n = 8). There were no group-by-time interactions for any studied outcomes. Post hoc analyses grouped participants by change in energy-adjusted Dietary Inflammatory Index (E-DII) score, noting that some intervention participants became more proinflammatory and several controls became more anti-inflammatory. Those with more anti-inflammatory dietary changes (below median E-DII change) showed differences in body fat percent (-1.27% vs +0.90%, P = .01), BMI (-0.66 vs +0.38 kg/m2, P = .06), and body weight (-0.99 vs +0.54 kg, P = .08).
Wirth MD, Shivappa N, Khan S, et al. Nutr Metab Insights, 2020. PMID 31975781